{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T05:30:07Z","timestamp":1737869407046,"version":"3.33.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212"],"award-info":[{"award-number":["INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212","INV-003212"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The World Health Organization conditionally recommends reactive drug administration to reduce malaria transmission in settings approaching elimination. However, few studies have evaluated the impact of reactive focal drug administration (rFDA) in sub-Saharan Africa, and none have evaluated it under programmatic conditions. In 2016, Senegal\u2019s national malaria control programme introduced rFDA, the presumptive treatment of compound members of a person with confirmed malaria, and reactive mass focal drug administration (rMFDA), an expanded effort including neighbouring compounds during an outbreak, in 10 low transmission districts in the north of the country. This evaluation sought to measure the impact of rFDA and rMFDA on malaria incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>An interrupted time series analysis was conducted with routine surveillance data on health post-level monthly confirmed malaria case counts from the District Health Information Software (DHIS2). The study evaluated the change in incidence following rFDA and rMFDA rollout (level change), which ranged from August 2016 to November 2019, and monthly thereafter (trend change), using an adjusted negative binomial regression model with data from January 2015 through January 2020. The model was used to estimate the number of cases averted via a counterfactual simulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No incidence rate reductions were estimated immediately following rollout (level change: incidence rate ratio (IRR)\u2009=\u20091.00, 95% credible interval (CI)\u2009=\u20090.76, 1.33). However, rFDA and rMFDA were associated with a 4% monthly decline in incidence relative to the baseline trend (trend change: IRR\u2009=\u20090.96, 95% CI\u2009=\u20090.95, 0.98). Over the study period, RFDA and rMFDA were estimated to avert 2,070 (95% CI\u2009=\u2009577, 4,367) of 4,108 (95% CI\u2009=\u20092,620, 6,425) malaria cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>RFDA and rMFDA were associated with reduced malaria incidence in northern Senegal, supporting their use in malaria control in very low transmission areas. However, additional strategies are likely needed to achieve elimination in this setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05245-5","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T08:54:52Z","timestamp":1737795292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating programmatic reactive focal drug administration impact on malaria incidence in northern Senegal: an interrupted time series analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ellen Leah","family":"Ferriss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakou","family":"Dieye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Ciss\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnagna","family":"Dieng Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Louis","family":"Lankia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Diedhiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiboulaye","family":"Sall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamba","family":"Souane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tidiane","family":"Thiam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou","family":"Sene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhadji","family":"Doucour\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahima","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Guinovart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"5245_CR1","unstructured":"WHO. Guidelines for malaria [Internet]. Geneva: World Health Organization; 2023. https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria."},{"key":"5245_CR2","doi-asserted-by":"crossref","unstructured":"Hsiang MS, Ntuku H, Roberts KW, Dufour M-SK, Whittemore B, Tambo M, et al. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial. Lancet. 2020;395:1361\u201373.","DOI":"10.1016\/S0140-6736(20)30470-0"},{"key":"5245_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12936-021-03761-8","volume":"20","author":"J Okebe","year":"2021","unstructured":"Okebe J, Dabira E, Jaiteh F, Mohammed N, Bradley J, Drammeh N-F, et al. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia. Malar J. 2021;20:253.","journal-title":"Malar J"},{"key":"5245_CR4","doi-asserted-by":"crossref","unstructured":"Vilakati S, Mngadi N, Benjamin-Chung J, Dlamini N, Dufour M-SK, Whittemore B, et al. Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin\u2013piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial. BMJ Glob Health. 2021;6:e005021.","DOI":"10.1136\/bmjgh-2021-005021"},{"key":"5245_CR5","doi-asserted-by":"publisher","first-page":"e0001295","DOI":"10.1371\/journal.pgph.0001295","volume":"2","author":"DJ Bridges","year":"2022","unstructured":"Bridges DJ, Miller JM, Chalwe V, Moonga H, Hamainza B, Steketee RW, et al. Reactive focal drug administration associated with decreased malaria transmission in an elimination setting: serological evidence from the cluster-randomized CoRE study. PLoS Glob Public Health. 2022;2:e0001295.","journal-title":"PLoS Glob Public Health"},{"key":"5245_CR6","unstructured":"U.S. President\u2019s Malaria Initiative Senegal. Malaria Operational Plan FY 2020 [Internet]. 2020. www.pmi.gov."},{"key":"5245_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/1475-2875-12-331","volume":"12","author":"M Littrell","year":"2013","unstructured":"Littrell M, Sow GD, Ngom A, Ba M, Mboup BM, Dieye Y, et al. Case investigation and reactive case detection for malaria elimination in northern Senegal. Malar J. 2013;12:331.","journal-title":"Malar J"},{"key":"5245_CR8","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1038\/s41467-021-23707-7","volume":"12","author":"A Bertozzi-Villa","year":"2021","unstructured":"Bertozzi-Villa A, Bever CA, Koenker H, Weiss DJ, Vargas-Ruiz C, Nandi AK, et al. Maps and metrics of insecticide-treated net access, use, and nets-per-capita in Africa from 2000\u20132020. Nat Commun. 2021;12:3589.","journal-title":"Nat Commun"},{"key":"#cr-split#-5245_CR9.1","unstructured":"Qader S, Abbott T, Boytinck E, Kuepie M, Lazar A, Tatem A. Census disaggregated gridded population estimates for Senegal (2020), version 1.0 [Internet]. University of Southampton"},{"key":"#cr-split#-5245_CR9.2","unstructured":"2022 [cited 2023 Sep 22]. https:\/\/data.worldpop.org\/repo\/wopr\/SEN\/population\/v1.0\/."},{"key":"5245_CR10","unstructured":"Thompson H. Defining urban areas based on population rasters [Internet]. 2022. https:\/\/path-global-health.github.io\/MNTD-tech-docs\/posts\/urban-rural-pathtools\/."},{"key":"5245_CR11","unstructured":"Eurostat. Territorial typologies manual - urban-rural typology [Internet]. 2020. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Territorial_typologies_manual_-_urban-rural_typology#Classes_for_the_typology_and_their_conditions."},{"key":"5245_CR12","unstructured":"United Nations. United Nations Demographic Yearbook 2021\/Nations Unies Annuaire demographique 2021. United Nations; 2022."},{"key":"5245_CR13","doi-asserted-by":"publisher","first-page":"150066","DOI":"10.1038\/sdata.2015.66","volume":"2","author":"C Funk","year":"2015","unstructured":"Funk C, Peterson P, Landsfeld M, Pedreros D, Verdin J, Shukla S, et al. The climate hazards infrared precipitation with stations\u2014a new environmental record for monitoring extremes. Sci Data. 2015;2:150066.","journal-title":"Sci Data"},{"key":"5245_CR14","unstructured":"Wan Z, Hook S, Hulley G. MODIS\/Terra Land Surface Temperature\/Emissivity Monthly L3 Global 6km SIN Grid V061 [Internet]. NASA EOSDIS Land Processes DAAC; 2021 [cited 2022 Sep 30]. https:\/\/lpdaac.usgs.gov\/products\/mod11b3v061\/."},{"key":"5245_CR15","unstructured":"Didan K. MODIS\/Terra Vegetation Indices Monthly L3 Global 1km SIN Grid V061 [Internet]. NASA EOSDIS Land Processes DAAC; 2021 [cited 2022 Sep 30]. https:\/\/lpdaac.usgs.gov\/products\/mod13a3v061\/."},{"key":"5245_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cageo.2016.08.020","volume":"97","author":"L Busetto","year":"2016","unstructured":"Busetto L, Ranghetti L. MODIStsp: an R package for automatic preprocessing of MODIS Land Products time series. Comput Geosci. 2016;97:40\u20138.","journal-title":"Comput Geosci"},{"key":"5245_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","volume":"71","author":"H Rue","year":"2009","unstructured":"Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested laplace approximations. J R Stat Soc B Stat Methodol. 2009;71:319\u201392.","journal-title":"J R Stat Soc B Stat Methodol"},{"key":"5245_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.csda.2013.04.014","volume":"67","author":"TG Martins","year":"2013","unstructured":"Martins TG, Simpson D, Lindgren F, Rue H. Bayesian computing with INLA: new features. Comput Stat Data Anal. 2013;67:68\u201383.","journal-title":"Comput Stat Data Anal"},{"key":"5245_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1467-9868.2011.00777.x","volume":"73","author":"F Lindgren","year":"2011","unstructured":"Lindgren F, Rue H, Lindstr\u00f6m J. An explicit link between Gaussian fields and Gaussian Markov random fields: the stochastic partial differential equation approach. J R Stat Soc B Stat Methodol. 2011;73:423\u201398.","journal-title":"J R Stat Soc B Stat Methodol"},{"key":"5245_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00116466","volume":"43","author":"J Besag","year":"1991","unstructured":"Besag J, York J, Molli\u00e9 A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43:1\u201320.","journal-title":"Ann Inst Stat Math"},{"key":"5245_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12936-016-1630-x","volume":"15","author":"LK Krisher","year":"2016","unstructured":"Krisher LK, Krisher J, Ambuludi M, Arichabala A, Beltr\u00e1n-Ayala E, Navarrete P, et al. Successful malaria elimination in the Ecuador-Peru border region: epidemiology and lessons learned. Malar J. 2016;15:573.","journal-title":"Malar J"},{"key":"5245_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.16-0734","volume":"97","author":"RA Ashton","year":"2017","unstructured":"Ashton RA, Bennett A, Yukich J, Bhattarai A, Keating J, Eisele TP. Methodological considerations for use of routine health information system data to evaluate malaria program impact in an era of declining malaria transmission. Am J Trop Med Hyg. 2017;97:46\u201357.","journal-title":"Am J Trop Med Hyg"},{"key":"5245_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/infdis\/jiaa434","volume":"225","author":"M Fraser","year":"2022","unstructured":"Fraser M, Miller JM, Silumbe K, Hainsworth M, Mudenda M, Hamainza B, et al. Evaluating the impact of programmatic mass drug administration for malaria in Zambia using routine incidence data. J Infect Dis. 2022;225:1415\u201323.","journal-title":"J Infect Dis"},{"key":"5245_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1536867X1501500208","volume":"15","author":"A Linden","year":"2015","unstructured":"Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J. 2015;15:480\u2013500.","journal-title":"Stata J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05245-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T08:55:00Z","timestamp":1737795300000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05245-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5245"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05245-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given all data included in the analysis were programmatic (i.e. collected during routine PNLP activities) and either aggregated or de-identified, no informed consent or ethics approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}